1. Home
  2. CRIS vs VCSA Comparison

CRIS vs VCSA Comparison

Compare CRIS & VCSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRIS
  • VCSA
  • Stock Information
  • Founded
  • CRIS 2000
  • VCSA 2009
  • Country
  • CRIS United States
  • VCSA United States
  • Employees
  • CRIS N/A
  • VCSA N/A
  • Industry
  • CRIS Biotechnology: Biological Products (No Diagnostic Substances)
  • VCSA Computer Software: Prepackaged Software
  • Sector
  • CRIS Health Care
  • VCSA Technology
  • Exchange
  • CRIS Nasdaq
  • VCSA Nasdaq
  • Market Cap
  • CRIS 32.8M
  • VCSA 38.6M
  • IPO Year
  • CRIS 2000
  • VCSA N/A
  • Fundamental
  • Price
  • CRIS $3.29
  • VCSA $5.01
  • Analyst Decision
  • CRIS Strong Buy
  • VCSA Hold
  • Analyst Count
  • CRIS 3
  • VCSA 4
  • Target Price
  • CRIS $23.00
  • VCSA $7.50
  • AVG Volume (30 Days)
  • CRIS 243.3K
  • VCSA 347.0K
  • Earning Date
  • CRIS 02-06-2025
  • VCSA 02-26-2025
  • Dividend Yield
  • CRIS N/A
  • VCSA N/A
  • EPS Growth
  • CRIS N/A
  • VCSA N/A
  • EPS
  • CRIS N/A
  • VCSA N/A
  • Revenue
  • CRIS $10,259,000.00
  • VCSA $949,936,000.00
  • Revenue This Year
  • CRIS N/A
  • VCSA N/A
  • Revenue Next Year
  • CRIS N/A
  • VCSA N/A
  • P/E Ratio
  • CRIS N/A
  • VCSA N/A
  • Revenue Growth
  • CRIS 0.44
  • VCSA N/A
  • 52 Week Low
  • CRIS $2.86
  • VCSA $2.07
  • 52 Week High
  • CRIS $17.49
  • VCSA $11.70
  • Technical
  • Relative Strength Index (RSI)
  • CRIS 44.97
  • VCSA 67.12
  • Support Level
  • CRIS $3.10
  • VCSA $4.80
  • Resistance Level
  • CRIS $3.60
  • VCSA $5.17
  • Average True Range (ATR)
  • CRIS 0.37
  • VCSA 0.17
  • MACD
  • CRIS 0.00
  • VCSA 0.01
  • Stochastic Oscillator
  • CRIS 26.22
  • VCSA 89.05

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

About VCSA Vacasa Inc.

Vacasa Inc is a vacation rental management platform in North America, transforming the vacation rental experience by integrating purpose-built technology with expert local and national teams.

Share on Social Networks: